| Primary |
| Drug Use For Unknown Indication |
42.1% |
| Atrial Fibrillation |
15.8% |
| Acute Coronary Syndrome |
7.9% |
| Arrhythmia |
7.9% |
| Prophylaxis |
7.9% |
| Myocardial Ischaemia |
5.3% |
| Depressed Mood |
2.6% |
| Diabetes Mellitus |
2.6% |
| Prevention |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Pulmonary Embolism |
2.6% |
|
| Drug Interaction |
14.3% |
| Heparin-induced Thrombocytopenia |
14.3% |
| Hypothrombinaemia |
14.3% |
| Shock Haemorrhagic |
14.3% |
| Syncope Vasovagal |
14.3% |
| Thrombosis |
14.3% |
| Upper Gastrointestinal Haemorrhage |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
36.9% |
| Drug Use For Unknown Indication |
24.1% |
| Hypertension |
5.6% |
| Prophylaxis |
3.9% |
| Thrombosis Prophylaxis |
3.2% |
| Pulmonary Embolism |
3.0% |
| Lung Infection |
2.5% |
| Atrial Fibrillation |
2.3% |
| Deep Vein Thrombosis |
2.0% |
| Pain |
2.0% |
| Urinary Tract Infection |
1.9% |
| Anaesthesia |
1.7% |
| Cardiac Failure |
1.6% |
| Arteriosclerosis Obliterans |
1.5% |
| Atrial Flutter |
1.5% |
| Arrhythmia |
1.4% |
| Arteriosclerosis |
1.2% |
| Lung Disorder |
1.2% |
| Thrombosis |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
|
| Thrombocytopenia |
28.4% |
| Renal Failure Acute |
9.9% |
| Toxic Skin Eruption |
7.8% |
| Tumour Lysis Syndrome |
7.8% |
| Haematoma |
6.0% |
| Gastrointestinal Haemorrhage |
4.3% |
| Shock Haemorrhagic |
4.3% |
| Anaemia |
3.9% |
| Jaundice |
3.0% |
| Renal Failure |
3.0% |
| Angioedema |
2.6% |
| Heparin-induced Thrombocytopenia |
2.6% |
| International Normalised Ratio Increased |
2.6% |
| Neutropenia |
2.6% |
| Rash Erythematous |
2.2% |
| Respiratory Distress |
2.2% |
| Cholestasis |
1.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.7% |
| Haematuria |
1.7% |
| Meningitis Aseptic |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
31.9% |
| Product Used For Unknown Indication |
18.8% |
| Hypertension |
6.4% |
| Pain |
4.7% |
| Unevaluable Event |
4.7% |
| Thrombosis Prophylaxis |
3.5% |
| Prophylaxis |
3.3% |
| Multiple Myeloma |
3.2% |
| Infection |
2.6% |
| Renal Transplant |
2.3% |
| Atrial Fibrillation |
2.2% |
| Respiratory Tract Infection |
2.1% |
| Epilepsy |
2.1% |
| Lung Disorder |
2.1% |
| Hiv Infection |
2.0% |
| Pneumonia |
2.0% |
| Diabetes Mellitus |
1.7% |
| Osteitis |
1.6% |
| Pulmonary Embolism |
1.5% |
| B-cell Lymphoma |
1.3% |
|
| Renal Failure Acute |
17.8% |
| Thrombocytopenia |
15.6% |
| Renal Failure |
9.8% |
| Neutropenia |
7.6% |
| Vanishing Bile Duct Syndrome |
5.5% |
| Pyrexia |
5.1% |
| Rhabdomyolysis |
5.1% |
| Toxic Skin Eruption |
4.7% |
| Malaise |
2.9% |
| Septic Shock |
2.9% |
| Urticaria |
2.9% |
| Death |
2.5% |
| Drug Interaction |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Vomiting |
2.5% |
| Overdose |
2.2% |
| Urinary Tract Infection |
2.2% |
| Acute Generalised Exanthematous Pustulosis |
1.8% |
| Anaemia |
1.8% |
| Cytolytic Hepatitis |
1.8% |
|
| Interacting |
| Atrial Fibrillation |
16.7% |
| Drug Use For Unknown Indication |
16.7% |
| Product Used For Unknown Indication |
13.3% |
| Hypercalcaemia |
10.0% |
| Anticoagulant Therapy |
8.3% |
| Depression |
6.7% |
| Urinary Tract Infection |
5.0% |
| Abnormal Behaviour |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Dyslipidaemia |
3.3% |
| Escherichia Infection |
3.3% |
| Intracardiac Thrombus |
3.3% |
| Type 1 Diabetes Mellitus |
3.3% |
| Heart Valve Replacement |
1.7% |
| Prophylaxis |
1.7% |
|
| International Normalised Ratio Increased |
21.1% |
| Drug Interaction |
15.8% |
| Pleural Effusion |
10.5% |
| Subcutaneous Haematoma |
10.5% |
| Haematoma |
5.3% |
| Haemorrhagic Anaemia |
5.3% |
| Hip Arthroplasty |
5.3% |
| Melaena |
5.3% |
| Muscle Haemorrhage |
5.3% |
| Overdose |
5.3% |
| Right Ventricular Failure |
5.3% |
| Thrombocytopenia |
5.3% |
|
